日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis

群体药代动力学和药效学模型预测特应性皮炎患者延长阿米利单抗3期给药方案

Tiraboschi, Gilles; Papp, Kim; Bieber, Thomas; Weidinger, Stephan; Beck, Lisa; Lee, Chih-Hung; O'Malley, John T; Yen, Karl; Bernigaud, Charlotte; Fabre, David; Hurbin, Fabrice

Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study

用于治疗特应性皮炎的抗OX40配体抗体Amlitelimab:STREAM-AD临床研究的通俗易懂的总结

Weidinger, Stephan; Blauvelt, Andrew; Papp, Kim A; Reich, Adam; Lee, Chih-Hung; Worm, Margitta; Lynde, Charles; Kataoka, Yoko; Foley, Peter; Wei, Xiaodan; Wong, Wanling; Solente, Anne-Catherine; Weber, Christine; Adelman, Samuel; Davey, Sonya; Hurbin, Fabrice; Rynkiewicz, Natalie; Yen, Karl; O'Malley, John T; Bernigaud, Charlotte

Engineering Radiocatalytic Nanoliposomes with Hydrophobic Gold Nanoclusters for Radiotherapy Enhancement

利用疏水性金纳米簇构建放射性催化纳米脂质体以增强放射治疗效果

Carigga Gutierrez, Nazareth Milagros; Clainche, Tristan Le; Bulin, Anne-Laure; Leo, Sofia; Kadri, Malika; Abdelhamid, Ahmed Gamal Ali; Pujol-Solé, Núria; Obaid, Girgis; Hograindleur, Marc-André; Gardette, Vincent; Busser, Benoit; Motto-Ros, Vincent; Josserand, Véronique; Henry, Maxime; Sancey, Lucie; Hurbin, Amandine; Elleaume, Hélène; Kandiah, Eaazhisai; Guével, Xavier Le; Coll, Jean-Luc; Broekgaarden, Mans

Population pharmacokinetic modeling and dosing simulation of avalglucosidase alfa for selecting alternative dosing regimen in pediatric patients with late-onset pompe disease

对晚发型庞贝病患儿进行阿伐葡萄糖苷酶α的群体药代动力学建模和剂量模拟,以选择替代给药方案

Tiraboschi, Gilles; Marchionni, David; Tuffal, Gilles; Fabre, David; Martinez, Jean-Marie; Haack, Kristina An; Miossec, Patrick; Kittner, Barbara; Daba, Nadia; Hurbin, Fabrice

Population Pharmacokinetic Modeling and Determination of Individual Exposure to Avalglucosidase Alfa in Adolescent and Adult Patients With Late-Onset Pompe Disease: Analysis of Pooled Data From Phase I to III Clinical Trials

青少年和成人晚发型庞贝病患者群体药代动力学模型及阿伐葡萄糖苷酶α个体暴露量测定:I期至III期临床试验汇总数据分析

Tuffal, Gilles; Tiraboschi, Gilles; Hurbin, Fabrice; Boittet, Pascale; Palmer, Rachel; Martinez, Jean-Marie; Fabre, David

Tumor-Specific Imaging with Angiostamp800 or Bevacizumab-IRDye 800CW Improves Fluorescence-Guided Surgery over Indocyanine Green in Peritoneal Carcinomatosis

在腹膜癌病中,使用Angiostamp800或Bevacizumab-IRDye 800CW进行肿瘤特异性成像可改善荧光引导手术的效果,优于吲哚菁绿引导手术。

Josserand, Véronique; Bernard, Claire; Michy, Thierry; Guidetti, Mélanie; Vollaire, Julien; Coll, Jean-Luc; Hurbin, Amandine

Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial

SAR247799 是一种 G 蛋白偏向性鞘氨醇-1-磷酸受体-1 激动剂,其在 2 型糖尿病大鼠和一项随机安慰剂对照患者试验中表现出内皮保护作用。

Bergougnan, Luc; Andersen, Grit; Plum-Mörschel, Leona; Evaristi, Maria Francesca; Poirier, Bruno; Tardat, Agnes; Ermer, Marcel; Herbrand, Theresa; Arrubla, Jorge; Coester, Hans Veit; Sansone, Roberto; Heiss, Christian; Vitse, Olivier; Hurbin, Fabrice; Boiron, Rania; Benain, Xavier; Radzik, David; Janiak, Philip; Muslin, Anthony J; Hovsepian, Lionel; Kirkesseli, Stephane; Deutsch, Paul; Parkar, Ashfaq A

Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth

靶向 CDK4/Cyclin D 界面的钉合肽与 Abemaciclib 联合使用可抑制 KRAS 突变肺癌生长

Celine Bouclier, Matthieu Simon, Guillaume Laconde, Morgan Pellerano, Sebastien Diot, Sylvie Lantuejoul, Benoit Busser, Laetitia Vanwonterghem, Julien Vollaire, Véronique Josserand, Baptiste Legrand, Jean-Luc Coll, Muriel Amblard, Amandine Hurbin, May C Morris

Population Pharmacokinetic/Pharmacodynamic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using an Indirect Response Model to Predict Low-Density Lipoprotein Cholesterol Lowering: Support for a Biologics License Application Submission: Part II

利用间接反应模型预测低密度脂蛋白胆固醇降低,对健康志愿者或高胆固醇血症患者进行阿利西尤单抗群体药代动力学/药效学分析:支持生物制品许可申请提交:第二部分

Nicolas, Xavier; Djebli, Nassim; Rauch, Clémence; Brunet, Aurélie; Hurbin, Fabrice; Martinez, Jean-Marie; Fabre, David

Population Pharmacokinetic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using a Michaelis-Menten Approximation of a Target-Mediated Drug Disposition Model-Support for a Biologics License Application Submission: Part I

利用靶向药物处置模型的米氏近似法对健康志愿者或高胆固醇血症患者进行阿利西尤单抗群体药代动力学分析——生物制品许可申请支持:第一部分

Martinez, Jean-Marie; Brunet, Aurélie; Hurbin, Fabrice; DiCioccio, A Thomas; Rauch, Clémence; Fabre, David